Has Thomas Koerner received payments from drug or device companies?

Yes. Drug and device makers reported $2,008 in general payments to Thomas Koerner across 65 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Thomas Koerner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Thomas Koerner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Thomas Koerner

Pediatrics · Frederick, MDNPI 1316942550

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,438 of the $2,008 with a category attached, or 71.6%. 21 manufacturers reported payments, led by GSK at 32.4% of the total. Reporting peaked in 2021 at $667 and has fallen 55.0% since, to $300 in 2025. Among pediatrics clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,008in general payments, 2019–2025

Across 65 payments — averaging $30.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$651
Merck$204
Cranial Technologies, Inc$150
Corium, LLC$136
Cumberland Pharmaceuticals, Inc.$135
Pfizer$120
plus $612 from 15 others

What the payments were for

Consulting fees$57028%
Food & beverage$1,43872%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	6	$651
Merck	7	$204
Cranial Technologies, Inc	10	$150
Corium, LLC	2	$136
Cumberland Pharmaceuticals, Inc.	3	$135
Pfizer	6	$120
Takeda Pharmaceuticals U.S.A., Inc.	5	$91
Seqirus USA Inc	3	$87
Ironshore Pharmaceuticals Inc.	4	$76
AstraZeneca	3	$61
Collegium Pharmaceutical, Inc.	2	$41
Sanofi Pasteur Inc.	2	$40
Kaleo, Inc.	2	$36
Neos Therapeutics, LP	2	$33
Sobi, Inc	2	$30
Sanofi-aventis U.S. LLC	1	$29
Ultragenyx Pharmaceutical Inc.	1	$22
Shire North American Group Inc	1	$22
ARS Pharmaceuticals Operations, Inc.	1	$16
Phadia US Inc.	1	$15
Kowa Pharmaceuticals America, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Azstarys$113

How this compares

$2,008 in reported general payments places this provider in the 90th percentile of 1,307 pediatrics providers in Maryland.

See all pediatrics providers in Maryland →

Other pediatrics in Frederick

Keith St AmandFrederick$4K
Jitendrakumar ModiAnnapolis$149K
Mary Elizabeth YoungerBaltimore$130K
Hari SachsRockville$114K
Brenda BanwellBaltimore$109K
Ellen FieldsSilver Spring$68K
John ThomsonBaltimore$67K
Carmelo CuffariBaltimore$61K
Victor AbdowRockville$58K
John PierceRockville$47K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →